603301.SS SHH
Zhende Medical Co., Ltd.
1W: -6.0%
1M: -8.0%
3M: -10.6%
YTD: -15.3%
1Y: +238.3%
3Y: +187.6%
5Y: +99.1%
¥75.17 ($11.21)
-0.63 (-0.83%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$7.6B
+4.3% ▲
5Y CAGR: +23.2%
Total Liabilities
$1.7B
+1.1% ▲
5Y CAGR: +5.8%
Shareholders Equity
$5.6B
+5.2% ▲
5Y CAGR: +32.9%
Cash & Investments
$828M
-31.4% ▼
5Y CAGR: +3.8%
Total Debt
$551M
+20.0% ▲
5Y CAGR: -5.1%
Net Debt
-$45M
+90.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.8B | $1.4B | $2.1B | $1.1B | $596M |
| Short-Term Investments | $204M | $5M | $100M | $156M | $232M |
| Cash & ST Investments | $2.0B | $1.4B | $2.2B | $1.2B | $828M |
| Net Receivables | $727M | $733M | $828M | $551M | $913M |
| Inventory | $1.1B | $833M | $930M | $801M | $771M |
| Other Current Assets | $292M | $304M | $236M | $161M | $67M |
| Total Current Assets | $4.4B | $3.2B | $4.1B | $2.7B | $2.6B |
| Property, Plant & Equip. | $1.5B | $2.2B | $2.5B | $2.8B | $3.2B |
| Goodwill & Intangibles | $356M | $843M | $1.0B | $1.4B | $1.5B |
| Long-Term Investments | $792K | $80M | $38M | $39M | -$38M |
| Other Non-Current Assets | $113M | $69M | $103M | $221M | $235M |
| Total Non-Current Assets | $2.0B | $3.2B | $3.8B | $4.5B | $4.9B |
| Total Assets | $6.4B | $6.4B | $7.9B | $7.3B | $7.6B |
| — Liabilities — | |||||
| Accounts Payable | $675M | $624M | $703M | $398M | $484M |
| Short-Term Debt | $358M | $661M | $124M | $220M | $267M |
| Deferred Revenue | $698M | $303M | $144M | $45M | $0 |
| Other Current Liabilities | $344M | $14M | $644M | $380M | $34M |
| Total Current Liabilities | $1.7B | $1.6B | $1.5B | $1.2B | $1.2B |
| Long-Term Debt | $95M | $145M | $388M | $200M | $283M |
| Other Non-Current Liab. | -$36M | $0 | -$176M | $0 | $0 |
| Total Non-Current Liabilities | $194M | $379M | $621M | $490M | $520M |
| Total Liabilities | $1.9B | $2.0B | $2.1B | $1.7B | $1.7B |
| — Equity — | |||||
| Common Stock | $227M | $227M | $266M | $266M | $266M |
| Retained Earnings | $2.8B | $2.9B | $3.4B | $3.1B | $3.4B |
| Accumulated OCI | $126M | $83M | $156M | $0 | $234M |
| Total Stockholders Equity | $4.2B | $4.1B | $5.5B | $5.4B | $5.6B |
| Total Liabilities & Equity | $6.4B | $6.4B | $7.9B | $7.3B | $7.6B |
| — Key Metrics — | |||||
| Total Debt | $453M | $848M | $564M | $460M | $551M |
| Net Debt | -$1.4B | -$510M | -$1.5B | -$477M | -$45M |
| Total Investments | $204M | $85M | $138M | $195M | $194M |